{"id":"https://openalex.org/W4361946201","doi":"https://doi.org/10.1158/1078-0432.c.6527364","title":"Data from Comparison of Biomarker Assays for EGFR: Implications for Precision Medicine in Patients with Glioblastoma","display_name":"Data from Comparison of Biomarker Assays for EGFR: Implications for Precision Medicine in Patients with Glioblastoma","publication_year":2023,"publication_date":"2023-03-31","ids":{"openalex":"https://openalex.org/W4361946201","doi":"https://doi.org/10.1158/1078-0432.c.6527364"},"language":"en","primary_location":{"id":"doi:10.1158/1078-0432.c.6527364","doi":"https://doi.org/10.1158/1078-0432.c.6527364","is_oa":true,"landing_page_url":"https://doi.org/10.1158/1078-0432.c.6527364","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},"volume":null,"type":"other","indexed_in":["crossref"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://doi.org/10.1158/1078-0432.c.6527364","any_repository_has_fulltext":null},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5057541817","display_name":"Andrew B. Lassman","orcid":"https://orcid.org/0000-0001-7386-9928","observed_orcids":["https://orcid.org/0000-0001-7386-9928"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Andrew B. Lassman","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5046267092","display_name":"Lisa A. Roberts-Rapp","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Lisa Roberts-Rapp","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5111358282","display_name":"\u0418\u0440\u0438\u043d\u0430 \u0421\u043e\u043a\u043e\u043b\u043e\u0432\u0430","orcid":"https://orcid.org/0000-0002-3659-7086","observed_orcids":["https://orcid.org/0000-0002-3659-7086"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Irina Sokolova","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5101198559","display_name":"Minghao Song","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Minghao Song","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5031259595","display_name":"Ekaterina V. Pestova","orcid":"https://orcid.org/0000-0001-8200-2621","observed_orcids":["https://orcid.org/0000-0001-8200-2621"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Ekaterina Pestova","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5108691500","display_name":"Rupinder K. Kular","orcid":"https://orcid.org/0009-0000-9840-6508","observed_orcids":["https://orcid.org/0009-0000-9840-6508"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Rupinder Kular","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5019051973","display_name":"Carolyn Mullen","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Carolyn Mullen","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5100569813","display_name":"Zheng Zha","orcid":"https://orcid.org/0009-0000-8489-7457","observed_orcids":["https://orcid.org/0009-0000-8489-7457"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Zheng Zha","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5032415518","display_name":"Xin Biao Lu","orcid":"https://orcid.org/0000-0002-3547-6493","observed_orcids":["https://orcid.org/0000-0002-3547-6493"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Xin Lu","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5079146812","display_name":"Erica J. Gomez","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Erica Gomez","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5036645151","display_name":"Anahita Bhathena","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Anahita Bhathena","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5059093147","display_name":"David Maag","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"David Maag","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5091750059","display_name":"Priya Kumthekar","orcid":"https://orcid.org/0000-0001-5923-0677","observed_orcids":["https://orcid.org/0000-0001-5923-0677"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Priya Kumthekar","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5010378038","display_name":"Hui Kong Gan","orcid":"https://orcid.org/0000-0001-7319-8546","observed_orcids":["https://orcid.org/0000-0001-7319-8546"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Hui K. Gan","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0001-7319-8546","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5078312966","display_name":"Andrew Mark Scott","orcid":"https://orcid.org/0000-0002-6656-295X","observed_orcids":["https://orcid.org/0000-0002-6656-295X"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Andrew M. Scott","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":null,"display_name":"Maria Guseva","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Maria Guseva","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5015092618","display_name":"Kyle D. Holen","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Kyle D. Holen","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5033578335","display_name":"Peter J. Ansell","orcid":"https://orcid.org/0000-0002-4088-2840","observed_orcids":["https://orcid.org/0000-0002-4088-2840"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Peter J. Ansell","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5010891460","display_name":"Martin J. van den Bent","orcid":"https://orcid.org/0000-0001-5710-5127","observed_orcids":["https://orcid.org/0000-0001-5710-5127"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Martin J. van den Bent","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0001-5710-5127","affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10129","display_name":"Glioma Diagnosis and Treatment","score":0.975600004196167,"subfield":{"id":"https://openalex.org/subfields/2716","display_name":"Genetics (clinical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10129","display_name":"Glioma Diagnosis and Treatment","score":0.975600004196167,"subfield":{"id":"https://openalex.org/subfields/2716","display_name":"Genetics (clinical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10755","display_name":"HER2/EGFR in Cancer Research","score":0.008999999612569809,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10417","display_name":"Lung Cancer Treatments and Mutations","score":0.005900000222027302,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/glioblastoma","display_name":"glioblastoma","score":0.9869999885559082},{"id":"https://openalex.org/keywords/egfr-amplification","display_name":"EGFR amplification","score":0.9869999885559082},{"id":"https://openalex.org/keywords/fluorescence-in-situ-hybridization","display_name":"fluorescence in situ hybridization","score":0.9120000004768372},{"id":"https://openalex.org/keywords/whole-exome-sequencing","display_name":"exome sequencing","score":0.9729999899864197},{"id":"https://openalex.org/keywords/rt-pcr","display_name":"RT-PCR","score":0.781000018119812},{"id":"https://openalex.org/keywords/rna-sequencing","display_name":"RNA sequencing","score":0.9010000228881836},{"id":"https://openalex.org/keywords/immunohistochemistry","display_name":"immunohistochemistry","score":0.9679999947547913},{"id":"https://openalex.org/keywords/egfr-mrna-expression","display_name":"EGFR mRNA expression","score":0.7639999985694885},{"id":"https://openalex.org/keywords/egfr-expression","display_name":"EGFR expression","score":0.6899999976158142},{"id":"https://openalex.org/keywords/assay-concordance","display_name":"assay concordance","score":0.7860000133514404},{"id":"https://openalex.org/keywords/precision-medicine","display_name":"precision medicine","score":0.8579999804496765},{"id":"https://openalex.org/keywords/anti-egfr-therapy","display_name":"anti-EGFR therapy","score":0.9509999752044678}],"concepts":[{"id":"https://openalex.org/C153911025","wikidata":"https://www.wikidata.org/wiki/Q7202","display_name":"Molecular biology","level":1,"score":0.4906655550003052},{"id":"https://openalex.org/C204232928","wikidata":"https://www.wikidata.org/wiki/Q899285","display_name":"Immunohistochemistry","level":2,"score":0.45736604928970337},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.3338123857975006},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.32597342133522034},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.32246828079223633},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.16676920652389526}],"mesh":[],"locations_count":2,"locations":[{"id":"doi:10.1158/1078-0432.c.6527364","doi":"https://doi.org/10.1158/1078-0432.c.6527364","is_oa":true,"landing_page_url":"https://doi.org/10.1158/1078-0432.c.6527364","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},{"id":"doi:10.1158/1078-0432.c.6527364.v1","doi":"https://doi.org/10.1158/1078-0432.c.6527364.v1","is_oa":true,"landing_page_url":"http://dx.doi.org/10.1158/1078-0432.c.6527364.v1","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"}],"best_oa_location":{"id":"doi:10.1158/1078-0432.c.6527364","doi":"https://doi.org/10.1158/1078-0432.c.6527364","is_oa":true,"landing_page_url":"https://doi.org/10.1158/1078-0432.c.6527364","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":0.9391000270843506,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2916215499","https://openalex.org/W2608516045","https://openalex.org/W2037370208","https://openalex.org/W4250118400","https://openalex.org/W2057697565","https://openalex.org/W2946676363","https://openalex.org/W2767539952","https://openalex.org/W2324431858","https://openalex.org/W2009508220","https://openalex.org/W1985417291"],"abstract_inverted_index":{"AbstractPurpose:":[0],"Patients":[1],"with":[2,66,161],"glioblastoma":[3],"(GBM)":[4],"have":[5],"a":[6,34,59],"poor":[7],"prognosis":[8],"and":[9,25,89,110,156,203],"are":[10,20,28],"in":[11,30,55,190,221],"desperate":[12],"need":[13],"of":[14,42,229],"better":[15],"therapies.":[16],"As":[17],"therapeutic":[18,36,240],"decisions":[19],"increasingly":[21],"guided":[22],"by":[23,46,122,152,165],"biomarkers,":[24],"EGFR":[26,44,64,80,96,117,148,162,192,198,218],"abnormalities":[27],"common":[29],"GBM,":[31],"thus":[32],"representing":[33],"potential":[35],"target,":[37],"we":[38,50],"systematically":[39],"evaluated":[40,51],"methods":[41,132],"assessing":[43,197],"amplification":[45,81,163,219],"multiple":[47],"assays.":[48,79],"Specifically,":[49],"correlation":[52],"among":[53,130],"fluorescence":[54],"situ":[56],"hybridization":[57],"(FISH),":[58],"standard":[60],"assay":[61],"for":[62,77,196,217,233],"detecting":[63],"amplification,":[65],"other":[67],"methods.":[68],"Experimental":[69],"Design:":[70],"Formalin-fixed,":[71],"paraffin-embedded":[72],"tumor":[73],"samples":[74],"were":[75,133,158],"used":[76,214],"all":[78],"was":[82,99,120,172,185],"detected":[83],"using":[84,101,135],"FISH":[85,166,177],"(N":[86],"=":[87,94,108,115,126,139,168,181],"206)":[88,109],"whole-exome":[90],"sequencing":[91,154],"(WES,":[92],"N":[93,107,114,125],"74).":[95],"mRNA":[97,149,199],"expression":[98,119,150,184,189,200,210],"measured":[100],"reverse":[102],"transcription-polymerase":[103],"chain":[104],"reaction":[105],"(RT-PCR,":[106,201],"transcriptome":[111],"profiling":[112],"(RNAseq,":[113],"64).":[116],"protein":[118,188,209],"determined":[121,134],"immunohistochemistry":[123],"(IHC,":[124],"34).":[127],"Significant":[128],"correlations":[129],"various":[131],"Cohen's":[136],"kappa":[137],"(\u03ba":[138,167,180],"0.61\u20130.80":[140],"defines":[141],"substantial":[142],"agreement)":[143],"or":[144],"R2":[145],"statistics.":[146],"Results:":[147],"levels":[151],"RNA":[153,183],"(RNAseq)":[155],"RT-PCR":[157],"highly":[159],"correlated":[160],"assessed":[164],"0.702).":[169],"High":[170],"concordance":[171],"also":[173],"observed":[174],"when":[175],"comparing":[176],"to":[178,187],"WES":[179],"0.739).":[182],"superior":[186],"delineating":[191],"amplification.":[193],"Conclusions:":[194],"Methods":[195],"RNAseq)":[202],"copy":[204],"number":[205],"(WES),":[206],"but":[207],"not":[208],"(IHC),":[211],"can":[212],"be":[213],"as":[215],"surrogates":[216],"(FISH)":[220],"GBM.":[222],"Collectively,":[223],"our":[224],"results":[225],"provide":[226],"enhanced":[227],"understanding":[228],"available":[230],"screening":[231],"options":[232],"patients,":[234],"which":[235],"may":[236],"help":[237],"guide":[238],"EGFR-targeted":[239],"approaches.":[241]},"counts_by_year":[],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2023-04-05T00:00:00"}